Antimicrobial susceptibility testing is crucial when treating Finegoldia magna infections
- PMID: 35391578
- DOI: 10.1007/s10096-022-04439-y
Antimicrobial susceptibility testing is crucial when treating Finegoldia magna infections
Abstract
Finegoldia magna is an anaerobic gram-positive bacterium that can cause invasive human infections. Recently, a 52-year-old patient suffering from a periprosthetic joint infection (PJI) due to F. magna was treated with cefepime on hemodialysis; however, treatment failed due to relapse caused by antibiotic-resistant strains. Reports on the antimicrobial susceptibility of F. magna clinical isolates are rare. We collected 57 clinical F. magna isolates from Zurich, Switzerland, between September 2019 and July 2020 and tested their antimicrobial susceptibility to investigate the local resistance pattern. Antimicrobial susceptibility testing (AST) was evaluated for nine antibiotics (benzylpenicillin, amoxicillin/clavulanic acid, cefuroxime, cefepime, levofloxacin, rifampicin, metronidazole, doxycycline, and clindamycin) by E-test according to CLSI guidelines. All F. magna strains were susceptible to benzylpenicillin, amoxicillin/clavulanic acid, and metronidazole, while 75% to clindamycin. F. magna isolates showed MIC values lower than species-unrelated breakpoints for cefuroxime, levofloxacin, and cefepime in 93%, 56%, and 32% of the cases, respectively. MIC values for rifampicin and doxycycline were lower than locally determined ECOFFs in 98% and 72% of the cases, respectively. In summary, we recommend the use of benzylpenicillin, amoxicillin/clavulanic acid, or metronidazole without prior AST as first-line treatment option against F. magna PJI infections. If cefuroxime, cefepime, levofloxacin, rifampicin, doxycycline, or clindamycin are used, AST is mandatory.
Keywords: Antimicrobial susceptibility; Cefepime; Finegoldia magna; Periprosthetic joint infection.
© 2022. The Author(s).
References
-
- Murdoch DA, Shah HN (1999) Reclassification of Peptostreptococcus magnus (Prevot 1933) Holdeman and Moore 1972 as Finegoldia magna comb. nov. and Peptostreptococcus micros (Prevot 1933) Smith 1957 as Micromonas micros comb. nov. Anaerobe 5(5):555–559 - DOI
-
- Murphy EC, Frick IM (2013) Gram-positive anaerobic cocci–commensals and opportunistic pathogens. FEMS Microbiol Rev 37(4):520–553 - DOI
-
- Söderquist B et al (2017) Finegoldia magna isolated from orthopedic joint implant-associated infections. J Clin Microbiol 55(11):3283–3291 - DOI
-
- Walter G et al (2014) Bone and joint infections due to anaerobic bacteria: an analysis of 61 cases and review of the literature. Eur J Clin Microbiol Infect Dis 33(8):1355–1364 - DOI
-
- Schulthess B et al (2013) Identification of Gram-positive cocci by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry: comparison of different preparation methods and implementation of a practical algorithm for routine diagnostics. J Clin Microbiol 51(6):1834–1840 - DOI
LinkOut - more resources
Full Text Sources